Celltrion

This study tests a new medicine called CT-P55 against the approved drug Cosentyx in 153 adults with moderate to severe plaque psoriasis. The goal is to see if CT-P55 works just as well and is as safe. Participants will receive either CT-P55 or Cosentyx, and doctors will measure c…

This study watches for side effects in 881 people with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, or psoriasis who receive Remsima under the skin. It aims to see how safe the injection is over time. Participants must have active disease that didn't respond…

This study is testing if adding a medication called pioglitazone helps adults with type 2 diabetes who still have high blood sugar despite taking two common drugs (metformin and empagliflozin). Researchers will compare pioglitazone to a placebo (dummy pill) in about 580 people to…

This early-stage study is testing how two experimental diabetes drugs (L03RD1 and L03RD2) work when given together, compared to a third drug (L03TD1) given alone. It involves 48 healthy adults aged 19 to 55. The main goal is to measure drug levels in the blood and check for any s…

This study tests two different devices (an auto-injector and a pre-filled syringe) for giving a single dose of the drug CT-P52. It involves 218 healthy men aged 19 to 55. The goal is to see if both methods deliver the drug into the body in a similar way and are safe.

This study tests whether a new biosimilar medicine called CT-P52 behaves like the approved drug Taltz in the body. It involves 218 healthy adults aged 19 to 55 who receive a single dose. The goal is to check if the two drugs are similar in terms of safety and how they are process…